• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在英国,乳腺癌的非标准管理随年龄增长而增加:一项基于≥65岁女性人群的队列研究。

Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years.

作者信息

Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M

机构信息

School of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK.

出版信息

Br J Cancer. 2007 Apr 23;96(8):1197-203. doi: 10.1038/sj.bjc.6603709. Epub 2007 Mar 27.

DOI:10.1038/sj.bjc.6603709
PMID:17387342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360138/
Abstract

Evidence suggests that compared to younger women, older women are less likely to receive standard management for breast cancer. Whether this disparity persists once differences in tumour characteristics have been adjusted for has not been investigated in the UK. A retrospective cohort study involving case note review was undertaken, based on the North Western Cancer Registry database of women aged > or =65 years, resident in Greater Manchester with invasive breast cancer registered over a 1-year period (n=480). Adjusting for tumour characteristics associated with age by logistic regression analyses, older women were less likely to receive standard management than younger women for all indicators investigated. Compared to women aged 65-69 years, women aged > or =80 years with operable (stage 1-3a) breast cancer have increased odds of not receiving triple assessment (OR=5.5, 95% confidence interval (CI): 2.1-14.5), not receiving primary surgery (OR=43.0, 95% CI: 9.7-191.3), not undergoing axillary node surgery (OR=27.6, 95% CI: 5.6-135.9) and not undergoing tests for steroid receptors (OR=3.0, 95% CI: 1.7-5.5). Women aged 75-79 years have increased odds of not receiving radiotherapy following breast-conserving surgery compared to women aged 65-69 years (OR=11.0, 95% CI: 2.0-61.6). These results demonstrate that older women in the UK are less likely to receive standard management for breast cancer, compared to younger women and this disparity cannot be explained by differences in tumour characteristics.

摘要

有证据表明,与年轻女性相比,老年女性接受乳腺癌标准治疗的可能性较小。在英国,尚未对在调整肿瘤特征差异后这种差异是否仍然存在进行调查。基于大曼彻斯特地区年龄≥65岁、居住在当地且在1年期间登记患有浸润性乳腺癌的女性的西北癌症登记数据库,开展了一项涉及病例记录回顾的回顾性队列研究(n = 480)。通过逻辑回归分析对与年龄相关的肿瘤特征进行调整后,在所有调查指标上,老年女性比年轻女性接受标准治疗的可能性更小。与65 - 69岁的女性相比,患有可手术(1 - 3a期)乳腺癌的≥80岁女性未接受三联评估的几率增加(比值比[OR]=5.5,95%置信区间[CI]:2.1 - 14.5),未接受初次手术的几率增加(OR = 43.0,95% CI:9.7 - 191.3),未进行腋窝淋巴结手术的几率增加(OR = 27.6,95% CI:5.6 - 135.9),未进行类固醇受体检测的几率增加(OR = 3.0,95% CI:1.7 - 5.5)。与65 - 69岁的女性相比,75 - 79岁的女性在保乳手术后未接受放疗的几率增加(OR = 11.0,95% CI:2.0 - 61.6)。这些结果表明,在英国,与年轻女性相比,老年女性接受乳腺癌标准治疗的可能性较小,且这种差异不能用肿瘤特征的差异来解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3458/2360138/eff7f63db822/6603709f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3458/2360138/eff7f63db822/6603709f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3458/2360138/eff7f63db822/6603709f1.jpg

相似文献

1
Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years.在英国,乳腺癌的非标准管理随年龄增长而增加:一项基于≥65岁女性人群的队列研究。
Br J Cancer. 2007 Apr 23;96(8):1197-203. doi: 10.1038/sj.bjc.6603709. Epub 2007 Mar 27.
2
Is lack of surgery for older breast cancer patients in the UK explained by patient choice or poor health? A prospective cohort study.英国老年乳腺癌患者手术不足是由患者选择还是健康状况不佳导致?一项前瞻性队列研究。
Br J Cancer. 2014 Feb 4;110(3):573-83. doi: 10.1038/bjc.2013.734. Epub 2013 Nov 28.
3
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.早期激素受体阳性乳腺癌患者的死亡率:丹麦基于人群的队列研究。
J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31.
4
Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.加利福尼亚州 1999-2004 年浸润性乳腺癌女性中,根据雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体 2(HER2)定义的乳腺癌亚型。
Breast J. 2009 Nov-Dec;15(6):593-602. doi: 10.1111/j.1524-4741.2009.00822.x. Epub 2009 Sep 17.
5
Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.与老年女性相比,40岁以下女性乳腺癌死亡率升高归因于早期疾病的较差生存率。
J Am Coll Surg. 2009 Mar;208(3):341-7. doi: 10.1016/j.jamcollsurg.2008.12.001. Epub 2009 Jan 21.
6
Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988-2011.1988 - 2011年美国IV期乳腺癌的初始手术与生存率
JAMA Surg. 2016 May 1;151(5):424-31. doi: 10.1001/jamasurg.2015.4539.
7
Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.刚果民主共和国和比利时女性乳腺癌的预后特征存在差异。
Breast. 2015 Oct;24(5):642-8. doi: 10.1016/j.breast.2015.07.031. Epub 2015 Aug 14.
8
Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer.早期激素受体阳性乳腺癌女性的淋巴结阳性率随年龄增长而降低。
Cancer. 2020 Mar 15;126(6):1193-1201. doi: 10.1002/cncr.32668. Epub 2019 Dec 20.
9
Age-related differences in breast cancer treatment.乳腺癌治疗中的年龄相关差异。
Ann Surg Oncol. 1994 Jan;1(1):45-52. doi: 10.1007/BF02303540.
10
Differences in breast cancer hormone receptor status in ethnic groups: a London population.不同族裔群体的乳腺癌激素受体状态差异:伦敦人群研究。
Eur J Cancer. 2013 Feb;49(3):696-702. doi: 10.1016/j.ejca.2012.09.012. Epub 2012 Oct 8.

引用本文的文献

1
Omission of multimodal therapy in older adults with high-risk breast cancer.老年高危乳腺癌患者多模式治疗的缺失
Breast Cancer Res Treat. 2025 May 20. doi: 10.1007/s10549-025-07728-0.
2
Racial disparities in presenting stage and surgical management among octogenarians with breast cancer: a national cancer database analysis.老年乳腺癌患者在就诊分期及手术治疗方面的种族差异:一项国家癌症数据库分析
Breast Cancer Res Treat. 2025 Feb;210(1):15-25. doi: 10.1007/s10549-024-07531-3. Epub 2024 Nov 4.
3
Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged ≥90 Years: A Large Retrospective Cohort Study.

本文引用的文献

1
Scottish Intercollegiate Guidelines Network (SIGN) 84 -- National Clinical Guideline for the Management of Breast Cancer in Women.苏格兰校际指南网络(SIGN)84——女性乳腺癌管理国家临床指南
Clin Oncol (R Coll Radiol). 2007 Oct;19(8):588-90. doi: 10.1016/j.clon.2007.06.006. Epub 2007 Jul 20.
2
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.他莫昔芬用于预防乳腺癌:国家外科辅助乳腺和肠道项目P-1研究的现状
J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62. doi: 10.1093/jnci/dji372.
3
Guidelines for the management of symptomatic breast disease.
≥90 岁老年乳腺癌患者以手术治疗为主:一项大型回顾性队列研究。
Ann Surg Oncol. 2024 Oct;31(11):7377-7391. doi: 10.1245/s10434-024-15790-z. Epub 2024 Aug 4.
4
Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels.雌激素受体阳性早期乳腺癌老年女性的生存结局:按合并症和虚弱程度比较原发性内分泌治疗与手术治疗
Cancers (Basel). 2024 Feb 11;16(4):749. doi: 10.3390/cancers16040749.
5
Breast cancer in elderly patients: a clinicopathological review of a Nigerian database.老年患者的乳腺癌:尼日利亚数据库的临床病理回顾
Ecancermedicalscience. 2022 Dec 8;16:1484. doi: 10.3332/ecancer.2022.1484. eCollection 2022.
6
Breast radiotherapy in elderly women: myths, controversies, and current techniques in the adjuvant setting.老年女性的乳腺癌放疗:辅助治疗中的误区、争议及当前技术
Transl Cancer Res. 2020 Jan;9(Suppl 1):S37-S55. doi: 10.21037/tcr.2019.07.09.
7
Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey.老年低危早期乳腺癌患者的管理策略:医生调查。
Curr Oncol. 2021 Dec 21;29(1):1-13. doi: 10.3390/curroncol29010001.
8
Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study.早期乳腺癌系统辅助治疗达到圣加仑 2013 年标准:MCC-Spain 研究。
Sci Rep. 2021 Mar 8;11(1):5375. doi: 10.1038/s41598-021-84825-2.
9
Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer.观察性队列研究旨在确定可手术乳腺癌老年女性手术或原发性内分泌治疗率的变化程度和原因。
Eur J Surg Oncol. 2021 Feb;47(2):261-268. doi: 10.1016/j.ejso.2020.09.029. Epub 2020 Sep 30.
10
Long-Term Survival and Risk of Institutionalization in Onco-Geriatric Surgical Patients: Long-Term Results of the PREOP Study.老年肿瘤外科患者的长期生存和住院风险:PREOP 研究的长期结果。
J Am Geriatr Soc. 2020 Jun;68(6):1235-1241. doi: 10.1111/jgs.16384. Epub 2020 Mar 10.
有症状乳腺疾病的管理指南。
Eur J Surg Oncol. 2005 May;31 Suppl 1:1-21. doi: 10.1016/j.ejso.2005.02.006.
4
Breast cancer treatment guidelines in older women.老年女性乳腺癌治疗指南。
J Clin Oncol. 2005 Feb 1;23(4):783-91. doi: 10.1200/JCO.2005.04.175.
5
How do we manage breast cancer in the elderly patients? A survey among members of the British Association of Surgical Oncologists (BASO).我们如何管理老年乳腺癌患者?英国外科肿瘤学家协会(BASO)成员的一项调查。
Crit Rev Oncol Hematol. 2004 Nov;52(2):135-41. doi: 10.1016/j.critrevonc.2004.08.002.
6
Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.老年女性乳腺癌:疾病表现特征、与年轻绝经后患者相比的局部和全身治疗选择
Cancer. 2004 Sep 15;101(6):1302-10. doi: 10.1002/cncr.20535.
7
Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines.绝经后乳腺癌女性患者的分期及治疗随年龄的变化:指南遵循情况
Br J Cancer. 2004 Apr 19;90(8):1486-91. doi: 10.1038/sj.bjc.6601742.
8
Undertreatment strongly decreases prognosis of breast cancer in elderly women.治疗不足会严重降低老年女性乳腺癌的预后。
J Clin Oncol. 2003 Oct 1;21(19):3580-7. doi: 10.1200/JCO.2003.02.046. Epub 2003 Aug 11.
9
Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients.年龄较大预示着乳腺癌患者辅助化疗推荐率下降:来自符合化疗条件患者的三级医疗队列研究证据。
Cancer. 2003 May 1;97(9):2150-9. doi: 10.1002/cncr.11338.
10
Factors influencing treatment patterns of breast cancer patients age 75 and older.
Crit Rev Oncol Hematol. 2003 May;46(2):121-6. doi: 10.1016/s1040-8428(02)00133-6.